首页> 美国卫生研究院文献>other >Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells
【2h】

Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells

机译:CD8 T细胞对MHC I类缺陷型骨髓的同种异体排斥

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Avoidance of long-term immunosuppression is a desired goal in organ transplantation. Mixed chimerism offers a promising approach to tolerance induction, and we have aimed to develop low-toxicity, non-immunodepleting approaches to achieve this outcome. In a mouse model achieving fully MHC-mismatched allogeneic bone marrow engraftment with minimal conditioning (3 Gy total body irradiation followed by anti-CD154 and T cell-depleted allogeneic bone marrow cells), CD4 T cells in the recipient are required to promote tolerance of pre-existing alloreactive recipient CD8 T cells and thereby permit chimerism induction. We now demonstrate that mice devoid of CD4 T cells and NK cells reject MHC class-I deficient and class I/class II-deficient marrow in a CD8 T cell-dependent manner. This rejection is specific for donor alloantigens, since recipient hematopoiesis is not affected by donor marrow rejection and MHC class-I deficient bone marrow that is syngeneic to the recipient is not rejected. Recipient CD8 T cells are activated and develop cytotoxicity against MHC class I-deficient donor cells in association with rejection. These data implicate a novel CD8 T cell-dependent bone marrow rejection pathway, wherein recipient CD8 T cells indirectly activated by donor alloantigens promote direct killing, in a TCR-independent manner, of class I-deficient donor cells.
机译:避免长期免疫抑制是器官移植的理想目标。混合嵌合体为诱导耐受性提供了一种有前途的方法,我们的目标是开发低毒,无免疫缺陷的方法以实现这一结果。在以最少的条件(3 Gy全身照射,然后用抗CD154和T细胞的同种异体骨髓细胞进行辐射)实现完全MHC不匹配的同种异体骨髓移植的小鼠模型中,受体中的CD4 T细胞需要增强对MHC的耐受性预先存在同种反应性受体CD8 T细胞,从而允许嵌合体诱导。我们现在证明,缺乏CD4 T细胞和NK细胞的小鼠以CD8 ​​T细胞依赖性方式排斥MHC I类缺陷和I / II类缺陷骨髓。该排斥对于供体同种异体抗原是特异性的,因为受体造血作用不受供体骨髓排斥的影响,并且与受体同基因的MHC I类缺陷骨髓也不会被排斥。受体CD8 T细胞被激活,并与排斥反应相关,发展出针对MHC I类缺陷供体细胞的细胞毒性。这些数据暗示了一种新颖的CD8 T细胞依赖性骨髓排斥途径,其中由供体同种抗原间接激活的受体CD8 T细胞以非TCR依赖性方式促进I类缺陷供体细胞的直接杀伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号